Where research peptides come from

Ask where a research peptide came from and the honest answer is usually "the seller's website." Almost nobody knows what happened before that, and the product page rarely says. This piece traces the route from a chemistry bench to a vial in a padded envelope, because the route explains most of what is confusing about this market: why the same product appears under a dozen names, why prices vary so much for what may be identical material, and why a certificate on a product page tells you less than it seems to.

The short version: research peptides are synthetic. Most are made in bulk by contract manufacturers, sold by the gram, divided into vials somewhere along the way, and sold online under many brand names, most of which are labels rather than makers.

How a peptide is made

A peptide is a chain of amino acids in a specific order. Making one means building that chain one amino acid at a time, and since the 1960s the standard way to do it has been solid-phase synthesis. The first amino acid is anchored to tiny resin beads, and each subsequent one is added in a cycle of chemical steps, with washing between cycles. Machines run the cycles now. When the chain is complete it is cut from the resin, and at that point it is a crude mixture: the intended peptide, plus chains that missed a step, chains with a wrong step, and leftover chemistry.

Purification comes next, usually by preparative HPLC, the industrial-scale cousin of the technique used to measure purity. Fractions rich in the target peptide are collected and the rest is discarded. The purified peptide is then freeze-dried into a powder. Because of the acid used in synthesis and purification, that powder is usually a salt of the peptide, most often with trifluoroacetate, sometimes swapped for acetate in an extra step. It also holds some water. That is why a gram of powder is never a gram of peptide, a point that matters later.

Who makes it

The manufacturers are contract synthesis houses: companies that make peptides to order for anyone who asks, including pharmaceutical companies, universities and resellers. Many of them are in China, where much of the world's peptide synthesis capacity is; others are in the United States, Europe and India. They sell by the gram or the kilogram, and a single synthesis batch can be large enough to supply many resellers.

At this stage the material generally has a real identity: a manufacturer's batch number and a manufacturer's certificate of analysis describing the bulk powder. That certificate describes the bulk. It cannot describe a vial, because there are no vials yet.

From bulk to vial

Somebody has to divide a jar of powder into vials of a stated amount. Sometimes the manufacturer does it. Sometimes a distributor does. Sometimes the reseller does, or has a third party do it. The powder may be dissolved, dispensed into vials as a solution and freeze-dried again in the vial, or it may be weighed in as powder.

This step is where the amount in each vial is set, and it is the step nobody upstream can vouch for. A manufacturer's certificate says the bulk was 99% pure; it says nothing about whether the person with the filling equipment put 10 mg in each vial or 7, or whether that 10 mg was peptide or powder. Whoever fills the vials also usually labels them, and in this market the label usually names the compound and an amount and nothing else. No batch number, no filler's name. We explain what that costs the buyer in why an unmarked peptide vial means a certificate can describe anything.

Brands and resellers

The last step is the one buyers can see. Online resellers buy vials, filled or unfilled, labeled or not, and sell them under their own names. Some resellers fill their own. Many buy finished vials and apply a label. A "brand" in this market is very often a label, a website and a customer-service inbox, with the material coming from the same handful of upstream sources as everyone else's.

That has three consequences.

The same material appears under many names. Two competitors may be selling vials from the same manufacturer's batch, or even the same filling run, at different prices, with different certificates on the page.

Prices reflect margins and marketing more than material. A higher price may mean better sourcing, more testing, or nothing at all, and from the outside there is no telling which.

Information is lost at every handoff. The manufacturer knows the batch. The filler knows which batch went into which run. The reseller may know some of that. The buyer knows none of it, because nothing on the vial carries it forward.

The certificate that traveled

One thing does travel down the chain: the manufacturer's certificate of analysis for the bulk powder. It is common for the certificate on a product page to be exactly that, sometimes with the manufacturer's name removed. It may be entirely accurate. It still describes a jar of powder that existed before the vial did, and it can't say what the vial holds. A reseller who commissions a test of the finished vial is doing something different and more useful. In our guide to how to read a peptide certificate of analysis, the section on what was tested, and when, is where the difference shows.

What this means for a buyer

The useful questions in this market are about the batch, not the brand. Which manufacturer's batch did this vial come from? Who filled it, and was the finished vial tested, or only the bulk? Was the amount measured, or copied from the label? A reseller's reputation can't answer any of those, and the label usually doesn't try.

None of this is a criticism of resellers, most of whom are working with exactly the information described here and no more. It is a description of a supply chain built for volume rather than traceability. The fix is not to trust a different link in the chain. It is to attach the record to the batch, and the batch to the vial, in a way the buyer can check.